Cubist Systematic Strategies’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50,993
| Closed | -$475K | – | 2227 |
|
|
2023
Q4 | $475K | Buy |
+50,993
| New | +$475K | ﹤0.01% | 1373 |
|
|
2023
Q1 | – | Sell |
-119,600
| Closed | -$1.11M | – | 2839 |
|
|
2022
Q4 | $1.11M | Sell |
119,600
-5,872
| -5% | -$54.4K | 0.01% | 1681 |
|
|
2022
Q3 | $1.3M | Buy |
125,472
+91,979
| +275% | +$949K | 0.01% | 1887 |
|
|
2022
Q2 | $335K | Sell |
33,493
-23,787
| -42% | -$238K | ﹤0.01% | 2863 |
|
|
2022
Q1 | $705K | Buy |
57,280
+46,888
| +451% | +$577K | 0.01% | 2284 |
|
|
2021
Q4 | $180K | Sell |
10,392
-4,000
| -28% | -$69.3K | ﹤0.01% | 3064 |
|
|
2021
Q3 | $258K | Sell |
14,392
-23,596
| -62% | -$423K | ﹤0.01% | 2442 |
|
|
2021
Q2 | $868K | Buy |
37,988
+27,158
| +251% | +$621K | 0.01% | 1677 |
|
|
2021
Q1 | $162K | Buy |
+10,830
| New | +$162K | ﹤0.01% | 2536 |
|
|
2020
Q4 | – | Sell |
-11,684
| Closed | -$53K | – | 2555 |
|
|
2020
Q3 | $53K | Sell |
11,684
-6,133
| -34% | -$27.8K | ﹤0.01% | 2360 |
|
|
2020
Q2 | $88K | Buy |
+17,817
| New | +$88K | ﹤0.01% | 2216 |
|
|
2016
Q1 | – | Sell |
-17,570
| Closed | -$98K | – | 1601 |
|
|
2015
Q4 | $98K | Buy |
+17,570
| New | +$98K | 0.01% | 1512 |
|